Show Search Form
human indexable | ||||||||
---|---|---|---|---|---|---|---|---|
published | ||||||||
registered interest | ||||||||
answer date | ||||||||
date | ||||||||
date tabled | ||||||||
ddp created | ||||||||
answering body |
|
|||||||
question status | Tabled | |||||||
answering dept id | 17 | |||||||
answering dept short name | Health and Social Care | |||||||
answering dept sort name | Health and Social Care | |||||||
ddp modified |
|
|||||||
hansard heading | Rare Diseases: Drugs | |||||||
house id | 1 | |||||||
identifier | 202091 | |||||||
legislature |
|
|||||||
parliament number | 57 | |||||||
question first answered |
|
|||||||
question text | To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the UK remains a world leader for the treatment of rare diseases after the UK leaves the EU. | |||||||
session |
|
|||||||
session number | 1 | |||||||
tabling member constituency | Linlithgow and East Falkirk | |||||||
tabling member printed |
|
|||||||
title | House of Commons Tabled Parliamentary Question 2017/19 202091 | |||||||
type |
|
|||||||
uin | 202091 | |||||||
version | 1 | |||||||
written parliamentary question type | Ordinary | |||||||
answer | answer | |||||||
creator |
|
|||||||
publisher |
|
|||||||
tabling member |
|